The disease spectrum of clinical phenotypes caused by mutations in PKHD1 is relatively complex, ranging from perinatally-fatal ARPKD to Congenital Hepatic Fibrosis (CHF)-predominant presentations in adulthood with mild or no apparent kidney disease [23]. This evidence concerns the gene PKHD1 and polycystic kidney disease 4.